186 related articles for article (PubMed ID: 25804379)
21. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.
Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M
Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999
[TBL] [Abstract][Full Text] [Related]
22. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
Albarel F; Conte-Devolx B; Oliver C
Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
[TBL] [Abstract][Full Text] [Related]
23. Follicular thyroid carcinoma: chromosome analysis of 19 cases.
Roque L; Clode A; Belge G; Pinto A; Bartnitzke S; Santos JR; Thode B; Bullerdiek J; Castedo S; Soares J
Genes Chromosomes Cancer; 1998 Mar; 21(3):250-5. PubMed ID: 9523201
[TBL] [Abstract][Full Text] [Related]
24. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
Roth LM; Miller AW; Talerman A
Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
[TBL] [Abstract][Full Text] [Related]
25. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification.
Pulcrano M; Boukheris H; Talbot M; Caillou B; Dupuy C; Virion A; De Vathaire F; Schlumberger M
Thyroid; 2007 Jul; 17(7):639-46. PubMed ID: 17696834
[TBL] [Abstract][Full Text] [Related]
26. Unusual tumors of the thyroid gland.
Baloch ZW; LiVolsi VA
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):297-310, vii. PubMed ID: 18502328
[TBL] [Abstract][Full Text] [Related]
27. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
Liu T; Wang N; Cao J; Sofiadis A; Dinets A; Zedenius J; Larsson C; Xu D
Oncogene; 2014 Oct; 33(42):4978-84. PubMed ID: 24141777
[TBL] [Abstract][Full Text] [Related]
28. p53 in a thyroid follicular carcinoma with foci of poorly differentiated and anaplastic carcinoma.
Matias-Guiu X; Villanueva A; Cuatrecasas M; Capella G; De Leiva A; Prat J
Pathol Res Pract; 1996 Dec; 192(12):1242-9; discussion 1250-1. PubMed ID: 9182295
[TBL] [Abstract][Full Text] [Related]
29. [Relationship of p53 gene mutation with pathological characteristics and prognosis of thyroid carcinoma].
Song Y; Wang L; Huang G; Yuan S; Xiao L
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):298-9, 314. PubMed ID: 12545813
[TBL] [Abstract][Full Text] [Related]
30. The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
Fukahori M; Yoshida A; Hayashi H; Yoshihara M; Matsukuma S; Sakuma Y; Koizume S; Okamoto N; Kondo T; Masuda M; Miyagi Y
Thyroid; 2012 Jul; 22(7):683-9. PubMed ID: 22650231
[TBL] [Abstract][Full Text] [Related]
31. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
32. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
33. Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant.
Di Cristofaro J; Marcy M; Vasko V; Sebag F; Fakhry N; Wynford-Thomas D; De Micco C
Hum Pathol; 2006 Jul; 37(7):824-30. PubMed ID: 16784981
[TBL] [Abstract][Full Text] [Related]
34. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
[TBL] [Abstract][Full Text] [Related]
35. Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications.
Menon MP; Khan A
J Clin Pathol; 2009 Nov; 62(11):978-85. PubMed ID: 19625289
[TBL] [Abstract][Full Text] [Related]
36. p53 mutations in all stages of thyroid carcinomas.
Zou M; Shi Y; Farid NR
J Clin Endocrinol Metab; 1993 Oct; 77(4):1054-8. PubMed ID: 8408453
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas.
Rodrigues RF; Roque L; Rosa-Santos J; Cid O; Soares J
Br J Cancer; 2004 Jan; 90(2):492-6. PubMed ID: 14735198
[TBL] [Abstract][Full Text] [Related]
38. Genetic and biological subgroups of low-stage follicular thyroid cancer.
French CA; Alexander EK; Cibas ES; Nose V; Laguette J; Faquin W; Garber J; Moore F; Fletcher JA; Larsen PR; Kroll TG
Am J Pathol; 2003 Apr; 162(4):1053-60. PubMed ID: 12651598
[TBL] [Abstract][Full Text] [Related]
39. Mutations of TSHR and TP53 Genes in an Aggressive Clear Cell Follicular Carcinoma of the Thyroid.
Tong GX; Mody K; Wang Z; Hamele-Bena D; Nikiforova MN; Nikiforov YE
Endocr Pathol; 2015 Dec; 26(4):315-9. PubMed ID: 26260781
[TBL] [Abstract][Full Text] [Related]
40. Aggressive variants of follicular cell derived thyroid carcinoma; the so called 'real thyroid carcinomas'.
Baloch Z; LiVolsi VA; Tondon R
J Clin Pathol; 2013 Sep; 66(9):733-43. PubMed ID: 23626010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]